Cerebral Blood Flow Measurement of MRI using PSO17 in Normal Subjects and Patients with Chronic Cerebrovascular Disorders
Not Applicable
- Conditions
- normal subjects and patients with chronic cerebrovascular disorders
- Registration Number
- JPRN-UMIN000009953
- Lead Sponsor
- Iwate Medical Univerisity
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 17
Inclusion Criteria
Not provided
Exclusion Criteria
(1) metallic implant or claustrophobia (2) chronic disorders (3) CNS, liver, kidney or heart diease (4) acute infection before 30 days (5) drug allergy (6) chronic intake of drugs (> 30 days) (7) other clinical trial (8) screening test (9) willing to have babies
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method (1) Signal difference of brain parenchyma between pre- and post-administration of PSO17 and saline (2) Temporal signal change after administration of PSO17 and saline
- Secondary Outcome Measures
Name Time Method (1) Efficacy 1) Correlation between blood flow image and PET in patient group (2) Safety 1) Vital signs (BP, HR, body temperature) 2) blood test and urine test 3) adverse effect